H, Y., & VC, W. (2017). Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin. Dove Medical Press.
Cita Chicago Style (17a ed.)H, Yu, y Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
Cita MLA (8a ed.)H, Yu, y Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.